Johnson Chemical Pharmaceutical Works Past Earnings Performance
Past criteria checks 2/6
Johnson Chemical Pharmaceutical Works has been growing earnings at an average annual rate of 5.2%, while the Pharmaceuticals industry saw earnings growing at 8.8% annually. Revenues have been growing at an average rate of 8.9% per year. Johnson Chemical Pharmaceutical Works's return on equity is 4.7%, and it has net margins of 12.6%.
Key information
5.2%
Earnings growth rate
1.0%
EPS growth rate
| Pharmaceuticals Industry Growth | 18.5% |
| Revenue growth rate | 8.9% |
| Return on equity | 4.7% |
| Net Margin | 12.6% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Could Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747) Have The Makings Of Another Dividend Aristocrat?
Mar 25
These 4 Measures Indicate That Johnson Chemical Pharmaceutical Works (GTSM:4747) Is Using Debt Reasonably Well
Feb 18Weak Financial Prospects Seem To Be Dragging Down Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747) Stock
Feb 01Estimating The Fair Value Of Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747)
Jan 12
Is Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747) An Attractive Dividend Stock?
Dec 25Johnson Chemical Pharmaceutical Works (GTSM:4747) Is Growing Earnings But Are They A Good Guide?
Dec 07Revenue & Expenses Breakdown
How Johnson Chemical Pharmaceutical Works makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 616 | 78 | 134 | 18 |
| 31 Mar 24 | 621 | 78 | 132 | 20 |
| 31 Dec 23 | 607 | 80 | 129 | 17 |
| 30 Sep 23 | 593 | 81 | 124 | 17 |
| 30 Jun 23 | 572 | 83 | 121 | 17 |
| 31 Mar 23 | 533 | 75 | 114 | 14 |
| 31 Dec 22 | 495 | 65 | 109 | 13 |
| 30 Sep 22 | 460 | 59 | 103 | 11 |
| 30 Jun 22 | 434 | 53 | 100 | 9 |
| 31 Mar 22 | 416 | 51 | 99 | 9 |
| 31 Dec 21 | 411 | 49 | 101 | 9 |
| 30 Sep 21 | 408 | 50 | 102 | 10 |
| 30 Jun 21 | 413 | 51 | 104 | 12 |
| 31 Mar 21 | 412 | 56 | 105 | 13 |
| 31 Dec 20 | 424 | 64 | 103 | 13 |
| 30 Sep 20 | 445 | 72 | 103 | 13 |
| 30 Jun 20 | 438 | 71 | 102 | 11 |
| 31 Mar 20 | 442 | 68 | 103 | 11 |
| 31 Dec 19 | 425 | 64 | 103 | 10 |
| 30 Sep 19 | 411 | 61 | 102 | 10 |
| 30 Jun 19 | 410 | 59 | 103 | 10 |
| 31 Mar 19 | 412 | 59 | 101 | 9 |
| 31 Dec 18 | 412 | 57 | 99 | 9 |
| 30 Sep 18 | 405 | 54 | 96 | 8 |
| 30 Jun 18 | 407 | 58 | 96 | 7 |
| 31 Mar 18 | 402 | 58 | 96 | 7 |
| 31 Dec 17 | 395 | 60 | 96 | 7 |
| 30 Sep 17 | 396 | 62 | 97 | 7 |
| 30 Jun 17 | 381 | 58 | 95 | 8 |
| 31 Mar 17 | 382 | 60 | 95 | 8 |
| 31 Dec 16 | 392 | 63 | 97 | 10 |
| 30 Sep 16 | 392 | 67 | 96 | 11 |
| 30 Jun 16 | 395 | 70 | 97 | 13 |
| 31 Mar 16 | 390 | 67 | 96 | 17 |
| 31 Dec 15 | 380 | 62 | 97 | 16 |
| 30 Sep 15 | 366 | 55 | 98 | 14 |
| 30 Jun 15 | 370 | 62 | 97 | 13 |
| 31 Mar 15 | 365 | 68 | 94 | 16 |
| 31 Dec 14 | 362 | 72 | 94 | 15 |
| 30 Sep 14 | 363 | 83 | 88 | 15 |
| 30 Jun 14 | 343 | 74 | 88 | 13 |
| 31 Mar 14 | 328 | 69 | 90 | 6 |
| 31 Dec 13 | 314 | 66 | 85 | 6 |
Quality Earnings: 4747 has high quality earnings.
Growing Profit Margin: 4747's current net profit margins (12.6%) are lower than last year (14.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 4747's earnings have grown by 5.2% per year over the past 5 years.
Accelerating Growth: 4747's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 4747 had negative earnings growth (-5.9%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (11.9%).
Return on Equity
High ROE: 4747's Return on Equity (4.7%) is considered low.